Monique E. C. M. Oud
University of Amsterdam
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Monique E. C. M. Oud.
Leukemia | 2014
W. Kraan; M. van Keimpema; H. M. Horlings; Esther J. M. Schilder-Tol; Monique E. C. M. Oud; L. A. Noorduyn; Philippus Kluin; Marie José Kersten; Marcel Spaargaren; S. T. Pals
High prevalence of oncogenic MYD88 and CD79B mutations in primary testicular diffuse large B-cell lymphoma
Leukemia | 2012
F van Maldegem; Thera A. M. Wormhoudt; M M S Mulder; Monique E. C. M. Oud; Esther J. M. Schilder-Tol; Alex R. Musler; Jan Aten; P Saeed; M.-J. Kersten; Steven T. Pals; C. J. M. Van Noesel; Richard J. Bende
Ocular adnexal marginal zone B-cell lymphomas (OAMZLs) arise in the connective tissues of the orbit or in the mucosa-associated lymphoid tissue of the conjunctiva. Here, we present the immunological and genetic analyses of 20 primary Chlamydia psittaci (Cp)-negative OAMZLs. Analysis of the immunoglobulin variable heavy chain (IgVH) gene usage demonstrated a significant preference for VH4-34. A combined analysis across all previously published OAMZLs confirmed that this is a general feature of OAMZL, in particular of the Cp-negative group. Our series of OAMZLs did not express the characteristic rheumatoid factor VHDJH rearrangements that were previously found in salivary gland- and gastric-marginal zone B-cell lymphomas (MZBCLs). We did not detect the MZBCL-specific chromosomal translocations, t(11;18) API2-MALT1 (mucosa-associated lymphoid tissue1) and t(14;18) IgH/MALT1. Two cases contained a premature stop codon in the A20 gene (TNFAIP3) and one case harbored the activating MYD88 hotspot mutation L265P. Variable nuclear expression of BCL10, NFκB1 (p50) and NFκB2 (p52) suggests that other additional genetic abnormalities affecting the NFκB pathway exist within this group of lymphomas. OAMZL showed variable expression of the chemokine receptor CXCR3 and integrin α4β7 by the tumor B cells, and low interferon-γ and interlukin-4 mRNA levels in the tissue, indicative of an inflammatory environment with features in between those previously found in cutaneous and other extranodal MZBCL. The strongly biased usage of VH4-34 in Cp-negative OAMZLs suggests involvement of a particular stimulatory (auto-) antigen in their development.
American Journal of Pathology | 2016
Linda M. Slot; Robbert Hoogeboom; Laura A. Smit; Thera A. M. Wormhoudt; Bart J. Biemond; Monique E. C. M. Oud; Esther J. M. Schilder-Tol; André B. Mulder; Aldo Jongejan; Antoine H. C. van Kampen; Philippus Kluin; Jeroen E. J. Guikema; Richard J. Bende; Carel J. M. van Noesel
Follicular lymphoma (FL) is an indolent B-cell non-Hodgkin lymphoma able to transform into germinal center-type diffuse large B-cell lymphoma. We describe four extraordinary cases of FL, which progressed to TdT+CD20- precursor B-lymphoblastic lymphoma (B-LBL). Fluorescence in situ hybridization analysis showed that all four B-LBLs had acquired a MYC translocation on transformation. Comparative genomic hybridization analysis of one case demonstrated that in addition to 26 numerical aberrations that were shared between the FL and B-LBL, deletion of CDKN2A/B and 17q11, 14q32 amplification, and copy-neutral loss of heterozygosity of 9p were gained in the B-LBL cells. Whole-exome sequencing revealed mutations in FMN2, NEB, and SYNE1 and a nonsense mutation in KMT2D, all shared by the FL and B-LBL, and TNFRSF14, SMARCA2, CCND3 mutations uniquely present in the B-LBL. Remarkably, all four FL-B-LBL pairs expressed IgG. In two B-LBLs, evidence was obtained for ongoing rearrangement of IG light chain variable genes and expression of the surrogate light chain. IGHV mutation analysis showed that all FL-B-LBL pairs harbored identical or near-identical somatic mutations. From the somatic gene alterations found in the IG and non-IG genes, we conclude that the FLs and B-LBLs did not develop in parallel from early t(14;18)-positive IG-unmutated precursors, but that the B-LBLs developed from preexistent FL subclones that accumulated additional genetic damage.
Leukemia Research | 2006
Marijn M.S. Mulder; Edou R. Heddema; Yvonne Pannekoek; Koorosh Faridpooya; Monique E. C. M. Oud; Esther J. M. Schilder-Tol; Peerooz Saeed; Steven T. Pals
Blood | 2001
Anton W. Langerak; Ingrid L. M. Wolvers-Tettero; Ellen J. van Gastel-Mol; Monique E. C. M. Oud; Jacques J.M. van Dongen
Cancer Research | 2008
Richard W.J. Groen; Monique E. C. M. Oud; Esther J. M. Schilder-Tol; Marije B. Overdijk; Derk ten Berge; Roel Nusse; Marcel Spaargaren; Steven T. Pals
Leukemia Research | 2010
Reinier H. van Rijssel; Jurgen Wegman; Monique E. C. M. Oud; Steven T. Pals; Marinus H. J. van Oers
Journal of Clinical Oncology | 2011
Sanne H. Tonino; Astrid L. Rijssenbeek; Monique E. C. M. Oud; Steven T. Pals; Marinus H. J. van Oers; Arnon P. Kater
Archive | 2010
Jacques J. M. van Dongen; Anton W. Langerak; Ingrid L. M. Wolvers-Tettero; Ellen J. van Gastel-Mol; Monique E. C. M. Oud
Nuclear Medicine Communications | 2006
Heike Schmidlin; Wendy Dontje; Fedde Groot; Suzanne J. Ligthart; Arnaud D. Colantonio; Monique E. C. M. Oud; Esther J. M. Schilder-Tol; Marcel Spaargaren; Hergen Spits; Christel H. Uittenbogaart; Bianca Blom